𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serum CA 19-9 as a Biomarker for Pancreatic Cancer—A Comprehensive Review

✍ Scribed by Umashankar K. Ballehaninna; Ronald S. Chamberlain

Book ID
107688948
Publisher
Springer-Verlag
Year
2011
Tongue
English
Weight
218 KB
Volume
2
Category
Article
ISSN
0975-7651

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum ca 50 as a tumor marker in pancrea
Serum ca 50 as a tumor marker in pancreatic cancer: A comparison with CA 19-9
✍ Caj Haglund; Pentti Kuusela; Hannu Jalanko; Peter J. Roberts 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 French ⚖ 459 KB

CA 50 is a new tumor marker based on a monoclonal anti-carcinoid tumor, 2 cystadenocarcinomas, 2 anaplastic carcibody (MAb) against a human colorectal carcinoma cell line.The nomas, 15 poorly differentiated and 39 well-to moderately-CA 50 antigen is similar, but not identical, to the tumor different

CA 19-9 as a prognostic index after rese
CA 19-9 as a prognostic index after resection for pancreatic cancer
✍ Cosimo Sperti; Claudio Pasquali; Sandra Catalini; Francesco Cappellazzo; Bruno B 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 485 KB

Serial serum CA 19-9 assays were performed in 30 consecutive patients who underwent resection for pancreatic cancer. Patients with preoperative CA 19-9 levels < 200 U/ml had significantly better prognosis than those with CA 19-9 > 200 Ulml ( P < 0.001). Serum tumor marker normalized in 14 patients a